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The aim of the present study was to determine the uterotonic activities of Ficus asperifolia and investigate its mechanism. The
eﬀects of aqueous and methanol extracts of the dried fruits of F. asperifolia (0.05–1.60mgmL−1) were evaluated on estrogenized
isolated rat uterus in the presence and absence of atropine (1.73–55.27nM), pyrilamine maleate (1.25 × 10−3 to 40 × 10−3 M),
indomethacin(0.06 ×10−5 to 2.00 ×10−5 M)orhexamethonium(0.66 × 10−4 to 21.43 × 10−4 M).Aqueous (EC50,0. 36mgmL −1)
and methanol (EC50,0 . 2 2m gm L −1)e x t r a c t sa sw e l la so x y t o c i n( E C 50, 0.02nM), acetylcholine (EC50,7 . 8 7n M )a n dh i s t a m i n e
(EC50, 0.76nM) evoked concentration-dependent contractions of the uterus. Atropine, pyrilamine maleate and indomethacin
concentration dependently blocked the response of the uterus to acetylcholine (IC50,4 . 8 2n M ) ,h i s t a m i n e( I C 50,2 . 4 9n M )a n d
oxytocin (IC50, 0.07nM), respectively, and to aqueous extract. Hexamethonium produced graded decreases in oxytocin-induced
uterinecontractions(IC50,0.37μM),butdidnotpreventthecontractileeﬀectsoftheaqueousextract (IC50,9.88μM).Theseresults
suggest that F. asperifolia-induced uterotonic eﬀect is related to the release of prostaglandins and contraction of the myometrial
cellsthroughmuscarinic,oxytocic andH1 histaminereceptors. Thesedatafurther giveaddedvaluetotheethnicuseofF. asperifolia
for its abortiﬁcient and contraceptive properties.
1.Introduction
The world population is estimated to reach 8.9 billion by the
year 2050, far higher than the 2004 estimate of 6.4 billion
[1, 2]. Population control is therefore needed for individual
and national welfare. Severaleﬀective contraceptive methods
exist and are used for fertility control among countries and
regions of the world. In the western societies, the pattern
use of female contraceptives varies from hormonal (steroidal
and non-steroidal molecules), surgical (sterilization) to
mechanical techniques (intrauterine devices, condom) [3].
In the developing countries where modern contraceptive
options are limited, >80% of the population continues to
use medicinal plants as extract, powder or decoction to
prevent unintended pregnancy or in family planning. Plants
like Hibiscus rosa-sinensis, Calotropis gigantean, Cissampelos
pareira and many others have been reported to exhibit some
contraceptive potentials [4–7]. Ficus asperifolia belonging
to the Moraceae family is also one of such plants. It is
a small or average size tree, terrestrial or epiphyte which
can reach 20m in height. It is found in Senegal, Uganda,
Tanzania, Natal (South Africa), Madagascar and Cameroon.
F. asperifolia is abundant in the savannah regions, especially
along river banks and marshy areas at an altitude of up to
1100m. The leaves are enormous and displayed spirally, the
limb is largely oval or has a form of ellipse and the roots
are most often ﬁbrous [8]. In many traditional medicines
of Africa, the leaf extract of F. asperifolia is used as an
anthelmintic and a purgative while the decoction of the
dried fruits and the bark extract are reputed for its fertility
regulation, abortiﬁcient and contraceptive properties [9].
However, these reports are still not scientiﬁcally investigated.
The aim of the present study was therefore to assess the
eﬀects of F. asperifolia on the isolated uterine tissue and
to propose its possible mechanism of action relevant to
its popular use as an abortiﬁcient/contraceptive. We used2 Evidence-Based Complementary and Alternative Medicine
t h ee s t r o g e n i z e di s o l a t e du t e r i n em o d e ls i n c ei th a db e e n
demonstrated that pre-treatment of females with estrogens
increases the responsiveness of the isolated uterus to drugs
exhibiting uterotonic activities [10–13].
2.Methods
2.1. Collection of Plant Material and Preparation of Extracts.
Fresh fruits of F. asperifolia (L) Hook. ex Miq. (Moraceae)
were collected in February 2006 from trees in Dschang,
Cameroon. Botanical identiﬁcation was performed in the
Cameroon National Herbarium (HNC) where a voucher
No. 338/15240/HNC has been deposited. The fruits were
shade-dried for 5 days and ground into powder. Two types
of extracts were used in the study. In order to obtain an
aqueous extract similar to the traditional recommendation,
1kgofF. asperifolia was soaked in distilled water (5L) and
the mixture boiled for 15min. The heated decoction was
takenandallowed tocoolatroomtemperature,ﬁlteredusing
Whatman paperNo.3andoven-driedtogive46.67gofdried
aqueous extract (yield of extraction, 4.66%; w/w based on
the dried starting weight). To obtain the methanol extract,
1kgofF. asperifolia powder was soaked in 5L of methanol
(95%) for 24h. The extract was ﬁltered using Whatman
paperNo.3and theﬁltrate wasevaporated(78◦C)todryness
using a rotary evaporator; 50g of dried methanol extract
was obtained giving an extraction yield of 5% (w/w based
on the dried starting weight). For bioactivity investigations,
theaqueousandmethanol extracts were dissolvedindistilled
water and 5% Tween 80, respectively.
2.2. Preliminary Phytochemical Screening. The freshly pre-
pared aqueous and methanol extracts were tested for the
presence of chemical constituents employing standard pro-
cedures including the Libermann Buchard’s test for the
existence of sterols and triterpens, the test of Shinoda for the
presence of ﬂavonoids and the test for saponins as described
by Hosttetmann et al. [14–17].
2.3. Animals. Healthy non pregnant adult female Wistar rats
between 10 and 12 weeks of age and weighing 150–170g
were used in this study. They were housed in groups (ﬁve
per group in polypropylene cages) and maintained under
uniform husbandry conditions having natural photoperiod,
humidity, temperature (26 ± 2◦C) and free access to food
and water. The Local Committee of Ethics on Animal Exper-
imentation approved all experimental procedures, which
followed the regulations established by the European Union
onAnimalCareandExperimentation(CEECouncil86/609).
2.4. Experimental Design
2.4.1. Isolated Organ Preparation. To obtain the estrogenized
uterus, virgin female rats were subcutaneously injected with
17-β-estradiol benzoate (13.28nM per animal) and killed
24h later by decapitation.The uteri were promptly removed,
cleaned of the connective tissue and cut into strips of
about 1cm of length. Each uterine strip was mounted in
an organ bath of 20mL capacity containing fresh De Jalon
solution of the following composition (mM): NaCl 153.85,
KCl 5.64, CaCl2 0.55, MgSO4 0.08, NaOH 12.5 and glucose
2.78. The physiological salt solution (PSS) was maintained
at 37 ± 0.50◦C and continuously bubbled with air. The
preparation was allowed to equilibrate for 30min during
which the bathing solution was changed every 10min.
2.4.2. Drug Challenges. After 30min of equilibration period,
uterine contractile responses were elicited by adding non-
cumulativelyacetylcholine (0.50–17.60μM), oxytocin(0.05–
1.50μM), histamine (1.09–34.77μM), aqueous or methanol
extracts of F. asperifolia (0.05–1.60mgmL−1)t ot h eD e
Jalon solution. Each dose of the drugs was allowed to
act for 10min and the amplitude of contraction recorded.
The contractions were recorded by means of an iso-
tonic transducer (Ugo Basile, Italy) connected to a sin-
gle channel recorder (Ugo Basile, Italy) which was cal-
ibrated to record change in the tension generated on
g versus cm displacement basis. The tension applied
to the preparation was 0.71g. Atropine (1.73–55.27nM),
indomethacin (0.06×10−5 to 2.00×10−5 M), pyrilamine
maleate (1.25×10−3 to 40×10−3 M) and hexamethonium
(0.66×10−4 to 21.43×10−4 M) were used to antagonize in
a concentration-dependent manner the maximal response
of the isolated uterus to acetylcholine (0.50–17.60μM),
oxytocin (0.05–1.50μM) or histamine (1.09–34.77μM) and
to the aqueous extract of F. asperifolia (1.60mgmL−1), the
most eﬃcient extract.
2.4.3. Drugs. The following drugs of analytical grade quality
were purchased from Sigma Chemical (St Louis, MO, USA):
estradiol benzoate (17-β-diol 3-benzoate), acetylcholine hy-
drochloride [ethanaminium, 2-(acetyloxy)-N,N,N-trimeth-
yl-, chloride], oxytocin (α-eypophamine), histamine [2-(4-
imidazolyl)ethylamine dihydrochloride], indomethacin [1-
(4-chlorobenzyl)-5-methoxy-2-methyl-3-indoleacetic acid],
pyrilamine maleate [N-(4-methoxyphenyl) methyl-N ]a n d
hexamethonium chloride (N,N,N,N ,N ,N -hexamethyl-1,
6-hexanediaminium dichloride).Atropinesulfate[α-(hydro-
methyl) benzeneacetic 8-methyl-8-azabicyclo (3.2.1) oct-3-
yl-ester] was purchased from a local pharmacy.
2.4.4. Statistical Analysis. Data are expressed in mean
± SEM. One-way analysis of variance (ANOVA) followed
by post hoc Newman–Keuls were used to analyze statistical
diﬀerence among groups. In all experiments, the contractile
responses were expressed as a percentage of the maximal
contractile response to a reference drug. EC50 or IC50
values were calculated using GraphPad Prism version 3.00
for Windows, GraphPad Software, San Diego, CA, USA,
http://www.graphpad.com. A probability of P<. 05 was
accepted as signiﬁcant.
3.Results
3.1. Preliminary Phytochemical Analysis. The fresh aqueous
andmethanolextractsofF. asperifolia gaveapositivereaction
to alkaloids, saponins, sterols and triterpens.Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Representative traces showing the contractile activity of the isolated estrogenized uterus by the aqueous (b) and methanol (b)
extracts of F. asperifolia (0.05–1.6mg/ml). Between two consecutive concentrations (indicated by the arrows), the tissue was allowed to
equilibrate for 10–15min during which the uterus was washed at least two times.
3.2. F. asperifolia and Agonist-Induced Uterine Contraction.
Aqueous and methanol extracts of the dried fruits of F.
asperifolia evoked concentration-dependent contractions of
the rat uterine smooth muscle. In most preparations, phasic
contractions were developed at lower concentrations (0.05–
0.40mgmL−1) while a strong tonic contraction was usually
obtained with the concentration 1.60mgmL−1 (Figure 1).
Acetylcholine (0.50–17.60μM), oxytocin (0.05–1.50μM)
and histamine (1.09–34.77μM) also provoked contractions
of the uterine tissue with oxytocin being the most potent
(EC50, 0.02nM) compared to acetylcholine (EC50,7 . 8 7n M )
and histamine (EC50, 0.76nM). With reference to the
percentage of maximal amplitude of contraction induced by
the standard agonists used in this study, the aqueous extract
(EC50,0 . 3 6m gm L −1)o fF. asperifolia always increased (P<
.05 − .001) the amplitude of contraction of the uterine
smooth muscle at high concentrations (0.80–1.60mgmL−1)
whilst a tendency to low eﬀects was observed in the case of
methanol extract (EC50,0 . 2 2m gm L −1)( Figure 2).
3.3. Antagonist Studies. The evidence that aqueous extract
of F. asperifolia (EC50,0 . 3 6 m g k g −1),o x y t o c i n( E C 50,
0.02nM), acetylcholine (EC50,7 . 8 7 n M )a n dh i s t a m i n e
(EC50, 0.76nM) concentration dependently induced con-
tractions of the estrogenized rat uterus was clearly shown
in the present study (Figures 1 and 2). Atropine (1.73–
55.27nM) which is a non-speciﬁc muscarinic competi-
tive antagonist reduced in a concentration-dependent way
the maximal contractile responses to acetylcholine (IC50,
4.82nM) and aqueous extract of F. asperifolia (IC50,
12.58nM) (Figure 3(a)). Pre-treatment of uterine horns
with pyrilamine maleate (1.25×10−3 to 40×10−3 M), a
H1 histamine receptor antagonist, progressively and almost
equally abolished the contractile eﬀects of both histamine
(IC50, 2.49nM) and aqueous extract of F. asperifolia
(IC50,2 . 4 9n M )( Figure 3(c)). Indomethacin (0.06×10−5 to
2.00×10−5 M), an inhibitor of prostaglandin synthase, sup-
pressed both oxytocin (IC50, 0.07nM) and aqueous extract
(IC50, 1.17nM)-induced uterine contractions (Figure 3(b)).
Hexamethonium (0.66×10−4 to 21.43×10−4 M), a gan-
glionic blocking agent, did not aﬀect the contractile
responses induced by the aqueous extract (IC50,9 . 8 8 μM)
but produced graded decreases in oxytocin-induced uterine
contractions (IC50,0 . 3 7μM) (Figure 3(d)). It is noteworthy
mentioning that pyrilamine maleate similarly abolished the
contractile eﬀects of the aqueous extract of F. asperifolia
(1.60mgmL−1) and histamine (34.77μM), whereas right-
ward shift of the concentration-response curves to atropine
and indomethacin was observed.
4.Discussionand Conclusions
Results of the present study demonstrated the oxytocic-
like activities of F. asperifolia in the estrogenized isolated
rat uterus. The aqueous and methanol extracts produced
a concentration-dependent increase in contraction of the
estrogenized isolated rat uterus with the aqueous extract
(EC50,0 . 3 6m gm L −1) exhibiting the high eﬃcacy although
the methanol extract likely showed greater potency (EC50,
0.22mgmL−1). A great number of medicinal plants are
also known for their oxytocic potentials [10–13]. With
regard to the major concern of the study, data of this
work further highlight the uterotonic claimed activity of
this medicinal plant and which could mimic that of some
uterinecontractileagents.Withrespect totheconcentration-
dependent contractile responses evoked by acetylcholine,
histamine and oxytocin, many studies have indicated the
existence of abundant cholinergic receptors in the uterine4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Comparative mean concentration-response curves for aqueous and methanol extracts of F. asperifolia with oxytocin (X),
acteylcholine (Y) and histamine (Z). Each point represents mean of four experiments. ∗P<. 05; ∗∗P<. 01 signiﬁcant when compared
to methanol extract. +P<. 05; ++P<. 01; +++P<. 001 signiﬁcant when compared to standard agonist.
smooth muscle and that stimulation of myometrial mus-
carinic receptors by agonists such as acetylcholine causes
contraction of the uterus [18, 19]. It is also well established
that histamine receptors (H1 and H2) are present in the
uterus and the predominant response of histamine in this
tissue is contraction (H1 activity) [20]. Oxytocin, the most
potent of the endogenous oxytocics, acts on myometrial
oxytocin receptors (OT1a) to directly cause uterine con-
traction and on endometrial oxytocin receptors (OT1b)t o
stimulate prostaglandins and cholinergic releases leading
to uterine contraction [21–25]. Phospholipase C-mediated
mobilizationofmainlysarcoplasmicintracellularcalciumvia
inositol triphosphate is the major intracellular mechanism
after oxytocin, histamine and acetylcholine initiate signalEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Concentration-dependent eﬀects of atropine (a), indomethacin (b), pyrilamine maleate (c) and hexamethonium (d) on the
maximum contractile response of the isolated estrogenized uterus to the aqueous extract of F. asperifolia (1.6mg/mL). Acetylcholine,
oxytocin and histamine were used as standard agonists.Atropin, pyrilamine maleate and hexamethonium were administered 10 min before
addition of plant extract or standard agonists. Indomethacin was introduced 20 min before addition of oxytocin or aqueous extract. Each
bar represents mean of four experiments. ∗P<. 05; ∗∗P<. 01; ∗∗∗P<. 001 signiﬁcantwhen compared to standard agonist.
transductionbybindingtoGprotein-coupledreceptorinthe
cell membrane (Figure 4)[ 26–28].
In order to ascertain the involvement of cholinergic,
histaminergic and oxytocinergic pathways in the mechanism
of F. asperifolia-induced uterine contractions, the eﬀect of
the most active plant extract (aqueousextract) was evaluated
in the presence of adequate antagonists of these substances.
Thus, pre-treatment of uterine strips with atropine (1.73–
55.27nM), indomethacin (0.06×10−5 to 2.00×10−5 M)
or pyrilamine maleate (1.25×10−3 to 40×10−3 M) antag-
onised concentration dependently the maximal response
to the plant extract (1.60mgmL−1)a n dt ot h er e s p e c t i v e6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Schematic diagram of proposed mechanism of F. asper-
ifolia-induced contraction in estrogen-treated uterine muscle. For
detailed description, see Discussion section. FA: Ficus asperifolia;
H1: type 1 histamine receptor; OTR: oxytocin receptor; M2: type
2 muscarinic receptor; G: protein G; PLC: phospholipase C; Pg:
prostaglandin; PIP2: phosphatidylinositol 4,5 biphosphate; IP3:
inositol1,4,5 triphosphate.
agonists namely acetylcholine, oxytocin and histamine in
this order. The rightward shift curves observed in the
presence of atropine and indomethacin probably suggest
partial agonistic eﬀectsofthe aqueousextract ofF. asperifolia
to acetylcholine and oxytocin, respectively. The fact that
pyrilamine maleate equally inhibited the contractile eﬀects
of F. asperifolia and histamine indicates that F. asperifolia
especially it aqueous extract could be considered as a full
agonist to histamine (H1). These results imply that the
bioactive compounds found in the aqueous extract of F.
asperifolia appear to activate the endometrial and myome-
trialcellmembranereceptorsresultinginanuterotoniceﬀect
by a mode of action possibly via the prostaglandin synthesis
and the activation of cholinergic, oxytocic and/or histamine
receptors. Phytochemical screenings of the aqueous and
methanol extract of F. asperifolia have revealed the presence
of alkaloids and saponins. Data from the literature indicate
that these two well-known compounds possess uterine
stimulating eﬀects [29–31]. It could therefore be understood
that the presence of these biological principles in the extracts
of F. asperifolia, especially its aqueous extract, may account
fortheobserveduterinecontractileactivity. Theinvolvement
of muscarinic, oxytocic and H1 receptors was also found
to mediate uterine muscle contractility in response to some
plant extracts [11, 12, 23, 24]. Of great interest in this
study is the lack of eﬀect of the ganglionic blocking agent,
hexamethonium, on the contractile action of the aqueous
extract of F. asperifolia;t h i sﬁ n d i n gs e e m st oi n d i c a t et h a t
the crude aqueous extract-induced increase in myometrial
contractility is due to actions on post-ganglionic autonomic
nerve endings with involvement of many receptors and
further supports the hypothesis of an oxytocic-like potential
of the plant extract [19].
In conclusion, our data provide evidence to suggest that
F. asperifolia-induced uterotonic eﬀect in the estrogenized
isolated rat uterus is owing to a mechanism related to the
release of prostaglandins and contraction of the myometrial
cells through more than one mechanism including the
muscarinic,oxytocicandhistamine receptors.These ﬁndings
justify the traditional use of the plant for its abortiﬁcient
and contraceptive properties. However, in the absence of
a speciﬁc antagonist to oxytocin, it was not possible to
characterize the direct implication of oxytocic receptors in
the eﬀects of F. asperifolia. Further studies are therefore
needed to clearly elucidate the mode of contraceptive action
of this medicinal plant.
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